UAE becomes first country to approve RINVOQ as oral treatment for vitiligo

UAE becomes first to approve RINVOQ (upadacitinib) as once-daily oral treatment for non-segmental vitiligo in adults and adolescents 12 , expanding access to innovative therapy …